|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/18 | (2006.01) |
| C07D 498/18 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/439 | (2006.01) |
| (11) | Number of the document | 3694863 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18795807.9 |
| Date of filing the European patent application | 2018-10-04 | |
| (97) | Date of publication of the European application | 2020-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/057735 |
| Date | 2018-10-04 |
| (87) | Number | WO 2019/073347 |
| Date | 2019-04-18 |
| (30) | Number | Date | Country code |
| 201762570326 P | 2017-10-10 | US | |
| 201862727734 P | 2018-09-06 | US |
| (72) |
BOWLES, Paul , US
ROSE, Peter Robert , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE |
| CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE |